This trial tests the effects of THC and CBD on healthy adults and those with chronic kidney disease, including those on dialysis.
- Chronic Kidney Disease
18 Primary · 3 Secondary · Reporting Duration: 48 hours
Awards & Highlights
1 Treatment Group
1 of 1
24 Total Participants · 1 Treatment Group
Primary Treatment: THC/CBD · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is the use of THC/CBD officially backed by regulatory approval?
"Our in-house team has rated the safety of THC/CBD to be a 1, signifying limited evidence for both efficacy and security." - Anonymous Online Contributor
Are any slots for enrollment in this research still available?
"As per clinicaltrials.gov, this medical experiment is now recruiting volunteers. The study was first posted on January 11th 2023 and modified most recently on February 14th of the same year." - Anonymous Online Contributor
To what extent is this experiment being utilized by participants?
"Affirmative. According to clinicaltrials.gov, this experiment is currently recruiting individuals who meet the criteria of participation. The study was initially posted on November 1st 2023 and has since been edited on February 14th 2023; 24 volunteers are required across a single site." - Anonymous Online Contributor